Skip to main content
. Author manuscript; available in PMC: 2009 Aug 1.
Published in final edited form as: Pharmacogenomics. 2009 Feb;10(2):191–201. doi: 10.2217/14622416.10.2.191

Table 1.

Informational aspects essential to deal with in a meta-analysis of GWA datasets and selected examples

Epidemiological design features underlying each study and dataset
  Design features, with emphasis on peculiarities and potential sources of bias
Quality checks including
  Evaluation of Hardy-Weinberg equilibrium
  Missing rate
  Imputation accuracy scores
Analytical methods, definitions and adjustments used in each dataset
  Central versus local analysis
  Harmonized analysis of imputed genotypes
  Standardization, harmonization, consistency in outcome definition
  Standardization, harmonization, consistency in adjusting variables
Independence of the samples
  Adjusting for cryptic or overt relatedness
  Adjustment for population stratification
  Handling overlapping samples
Strand and build of the human genome on which individual study results are provided
  Handling of inconsistencies
Direct genotyping versus imputation
  Relative availability of directly genotype vs. imputed data
  Methods of imputation